Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorPIEPER, Pauline
dc.contributor.authorMCHUGH, Eliza
dc.contributor.authorAMARAL, Maiara
dc.contributor.authorTEMPONE, Andre G.
dc.contributor.authorANDERSON, Edward A.
dc.identifier.citationTETRAHEDRON, v.76, n.2, Special Issue, article ID 130814, 8p, 2020
dc.description.abstractChagas disease and visceral leishmaniasis are neglected protozoan diseases with significant impact in developing countries. Due to the limited number and toxicity of current therapies, new drug leads are urgently needed. In this work, four aporphine natural products were synthesized using an enantioselective, modular and convergent strategy, comprising eight steps in the longest linear sequence; key steps included Bischler-Napieralski cyclization/Noyori asymmetric reduction to construct the tetrahydroisoquinolines, and palladium-catalyzed arylation to close the C ring. Norglaucine, nordicentrine and dicentrine showed promising bioactivity against T. cruzi and L. infantum, suggesting potential for further development of these scaffolds as antiparasitic agents.eng
dc.description.sponsorshipSwiss National Science FoundationSwiss National Science Foundation (SNSF)
dc.description.sponsorshipMarie Sklodowska-Curie actions for an Individual Fellowship [832700]
dc.description.sponsorshipOxford Internal GCRF Research England Fund [0006019]
dc.description.sponsorshipEPSRCEngineering & Physical Sciences Research Council (EPSRC) [EP/M019195/1]
dc.description.sponsorshipSao Paulo State Research FoundationFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [FAPESP 2018/10279-6, 2018/25128-3]
dc.description.sponsorshipConselho Nacional de Pesquisa e DesenvolvimentoNational Council for Scientific and Technological Development (CNPq)
dc.subjectNatural productseng
dc.subjectLeishmania infantumeng
dc.subjectTrypanosoma cruzieng
dc.subjectPalladium catalyzed arylationeng
dc.titleEnantioselective synthesis and anti-parasitic properties of aporphine natural productseng
dc.rights.holderCopyright PERGAMON-ELSEVIER SCIENCE LTDeng
dc.subject.wosChemistry, Organiceng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng, Pauline:Univ Oxford, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England, Eliza:Univ Oxford, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England, Andre G.:Adolfo Lutz Inst, Ctr Parasitol & Mycol, Av Dr Arnaldo 351, BR-01246000 Sao Paulo, Brazil, Edward A.:Univ Oxford, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England
hcfmusp.description.issueSpecial Issue
hcfmusp.relation.referenceAmaral M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42273-zeng
hcfmusp.relation.referenceAnakabe E., 2004, SYNTHESIS-STUTTGART, V7, P1093eng
hcfmusp.relation.referenceAshina Y., 1909, ARCH PHARM, P201eng
hcfmusp.relation.referenceBuchanan MS, 2009, J NAT PROD, V72, P1541, DOI 10.1021/np9002564eng
hcfmusp.relation.referenceCAVA MP, 1972, J ORG CHEM, V37, P330, DOI 10.1021/jo00967a038eng
hcfmusp.relation.referenceChandrasekhar S, 2014, SYNTHETIC COMMUN, V44, P3008, DOI 10.1080/00397911.2014.926373eng
hcfmusp.relation.referenceChiu CC, 2012, MOLECULES, V17, P4357, DOI 10.3390/molecules17044357eng
hcfmusp.relation.referenceChrzanowska M, 2016, CHEM REV, V116, P12369, DOI 10.1021/acs.chemrev.6b00315eng
hcfmusp.relation.referenceDade J., 2017, J PHARMACOGN NAT PRO, P3eng
hcfmusp.relation.referenceDong JW, 2018, J PHARMACEUT BIOMED, V160, P330, DOI 10.1016/j.jpba.2018.08.007eng
hcfmusp.relation.referenceELOUMIROPIVIA J, 1984, J NAT PROD, V47, P1067, DOI 10.1021/np50036a046eng
hcfmusp.relation.referenceFerreira DD, 2019, EUR J MED CHEM, V176, P162, DOI 10.1016/j.ejmech.2019.05.001eng
hcfmusp.relation.referenceGies AE, 1999, EUR J ORG CHEM, V1999, P1957eng
hcfmusp.relation.referenceGraziose R, 2011, J ETHNOPHARMACOL, V133, P26, DOI 10.1016/j.jep.2010.08.059eng
hcfmusp.relation.referenceHoet S, 2004, PLANTA MED, V70, P407, DOI 10.1055/s-2004-818967eng
hcfmusp.relation.referenceHuang WJ, 2002, SYNTHETIC COMMUN, V32, P3681, DOI 10.1081/SCC-120014988eng
hcfmusp.relation.referenceKERR KM, 1986, J NAT PROD, V49, P576, DOI 10.1021/np50046a003eng
hcfmusp.relation.referenceKOHNO M, 1990, B CHEM SOC JPN, V63, P1252, DOI 10.1246/bcsj.63.1252eng
hcfmusp.relation.referenceKu AF, 2015, ORG LETT, V17, P1134, DOI 10.1021/acs.orglett.5b00007eng
hcfmusp.relation.referenceLafrance M, 2007, EUR J ORG CHEM, V2007, P811, DOI 10.1002/ejoc.200600674eng
hcfmusp.relation.referenceLekphrom R, 2009, J ETHNOPHARMACOL, V125, P47, DOI 10.1016/j.jep.2009.06.023eng
hcfmusp.relation.referenceLIKHITWITAYWUID K, 1993, J NAT PROD, V56, P1468, DOI 10.1021/np50099a005eng
hcfmusp.relation.referenceLiu CM, 2014, MOLECULES, V19, P17829, DOI 10.3390/molecules191117829eng
hcfmusp.relation.referenceMORELLO A, 1994, COMP BIOCHEM PHYS C, V107, P367, DOI 10.1016/1367-8280(94)90063-9eng
hcfmusp.relation.referenceMovassaghi M, 2008, ORG LETT, V10, P3485, DOI 10.1021/ol801264ueng
hcfmusp.relation.referenceOlivera R, 2002, J ORG CHEM, V67, P7215, DOI 10.1021/jo025767jeng
hcfmusp.relation.referenceOrito K, 2000, ORG LETT, V2, P307, DOI 10.1021/ol990360veng
hcfmusp.relation.referencePathe GK, 2015, SYNTHESIS-STUTTGART, V47, P3542, DOI 10.1055/s-0034-1378821eng
hcfmusp.relation.referencePingaew R, 2007, SYNLETT, P2363, DOI 10.1055/s-2007-985596eng
hcfmusp.relation.referencePinto EG, 2013, EXP PARASITOL, V135, P655, DOI 10.1016/j.exppara.2013.09.016eng
hcfmusp.relation.referenceReimao JQ, 2011, EXP PARASITOL, V128, P111, DOI 10.1016/j.exppara.2011.02.021eng
hcfmusp.relation.referenceShama V., 2018, CHEMMEDCHEM, V13, P1817eng
hcfmusp.relation.referenceSPANGLER RJ, 1974, J ORG CHEM, V39, P1368, DOI 10.1021/jo00926a010eng
hcfmusp.relation.referenceSTAUBER LA, 1958, J PROTOZOOL, V5, P269, DOI 10.1111/j.1550-7408.1958.tb02565.xeng
hcfmusp.relation.referenceTiwari N, 2018, MINI-REV MED CHEM, V18, P26, DOI 10.2174/1389557517666170425105129eng
hcfmusp.relation.referenceTran TTT, 2012, NAT PROD RES, V26, P1296, DOI 10.1080/14786419.2011.570761eng
hcfmusp.relation.referencevan Griensven J, 2012, INFECT DIS CLIN N AM, V26, P309, DOI 10.1016/j.idc.2012.03.005eng
hcfmusp.relation.referenceWang JJ, 2016, ORG LETT, V18, P3542, DOI 10.1021/acs.orglett.6b01496eng
hcfmusp.relation.referenceWei CY, 2018, MOLECULES, V23, DOI 10.3390/molecules23092286eng
hcfmusp.relation.referenceWorld Health Organization (WHO), 2017, INT NEGL TROP DIS GLeng
hcfmusp.relation.referenceWu JS, 2006, CHEM COMMUN, P1766, DOI 10.1039/b600496beng
hcfmusp.relation.referenceYan Q, 2017, BIOORGAN MED CHEM, V25, P6542, DOI 10.1016/j.bmc.2017.10.027eng
hcfmusp.relation.referenceZhong M, 2015, TETRAHEDRON-ASYMMETR, V26, P1145, DOI 10.1016/j.tetasy.2015.09.008eng
Appears in Collections:

Artigos e Materiais de Revistas Científicas - IMT
Instituto de Medicina Tropical - IMT

Files in This Item:
File Description SizeFormat 
  Restricted Access
publishedVersion (English)581.61 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.